STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues
Total revenues	$ 407,320	$ 333,615	$ 124,456
Costs and operating expenses
Cost of sales	39,537	50,556	17,795
Research and development	71,527	52,317	35,536
Selling, general and administrative	337,233	258,692	134,401
Total costs and operating expenses	448,297	361,565	187,732
Loss from operations	(40,977)	(27,950)	(63,276)
Interest expense	(20,102)	(13,006)	(4,950)
Non-cash interest expense related to the sale of future royalties	(8,296)	(7,088)	(3,924)
Other income, net	8,745	9,174	6,630
Loss before provision for income taxes	(60,630)	(38,870)	(65,520)
Provision for income taxes	969	266	547
Net loss	$ (61,599)	$ (39,136)	$ (66,067)
Net loss per share of common stock - basic (in dollars per share)	$ (0.26)	$ (0.17)	$ (0.30)
Net loss per share of common stock - diluted (in dollars per share)	$ (0.26)	$ (0.17)	$ (0.30)
Shares used in computing net loss per share - basic (in shares)	241,033,750	235,232,927	219,331,253
Shares used in computing net loss per share - diluted (in shares)	241,033,750	235,232,927	219,331,253
Comprehensive loss
Net loss	$ (61,599)	$ (39,136)	$ (66,067)
Unrealized gains (losses) on available-for-sale securities	141	(167)	278
Comprehensive loss	(61,458)	(39,303)	(65,789)
Product sales, net
Revenues
Total revenues	377,808	319,196	82,526
Product supply revenue
Revenues
Total revenues	15,879	11,649	6,121
Licensing revenue
Revenues
Total revenues	5,088	78	35,809
Non-cash royalty revenue related to the sale of future royalties
Revenues
Total revenues	$ 8,545	$ 2,692	$ 0